Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A.
Forward PE Ratio (N/A) = Close Price ($27.90) / Consensus Forward EPS ($-0.58)
FORWARD PE RATIO
N/A
Hims & Hers Health, Inc.
Market Cap
$6.22B
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Hims & Hers Health, Inc. (HIMS) | $6.22B | N/A |
| Scholar Rock Holding Corporation (SRRK)vs › | $6.55B | N/A |
| Chemed Corporation (CHE)vs › | $6.78B | 20.34 |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.21B | 20.31 |
| Doximity, Inc. (DOCS)vs › | $4.52B | 15.79 |
| Oscar Health, Inc. (OSCR)vs › | $8.23B | 19.15 |
| TransMedics Group, Inc. (TMDX)vs › | $2.99B | 59.50 |
| Insulet Corp. (PODD)vs › | $9.55B | 21.88 |
| The Ensign Group, Inc. (ENSG)vs › | $10.01B | 21.88 |
| Henry Schein, Inc. (HSIC)vs › | $10.02B | 16.50 |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus next-FY EPS
At today's $27.90 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-0.58 | $-1.03 – $-0.13 | 7 | n/m |
| 2027-12-31 | $0.30 | $0.23 – $0.38 | 8 | 92.0x |
| 2028-12-31 | $0.72 | $0.51 – $1.05 | 6 | 39.0x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
